Skip to content

The Staff Stop Smoking Project

A Randomised Feasibility Study Comparing a Novel Intervention for Smoking Cessation in NHS Staff to Standard Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04263545
Acronym
STOP
Enrollment
30
Registered
2020-02-10
Start date
2019-06-03
Completion date
2019-06-21
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

Participants will be randomised to either standard care or to receive our help to quit programme. The study will only be available to Portsmouth Hospital Trust staff member.

Detailed description

A randomised controlled feasibility study to trial a novel intervention to help NHS staff stop smoking compared to standard care. Participants will attend one-on-one interviews and a support group where they will undertake CO monitoring and mini-spirometry. They will complete questionnaires about their quality of life, other health problems and their general state of health. They will attend the support groups on a weekly basis and have access to support outside of these times.

Interventions

BEHAVIORALGroup session with smoking cessation counsellor

Group session with smoking cessation counsellor

BEHAVIORALStandard Care

standard care arm will receive very brief advice (VBA) and signposting to local organisations to support a quit.

Sponsors

Portsmouth Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

Participants who are randomised to the standard care arm will receive very brief advice (VBA) and signposting to local organisations to support a quit smoking.

Intervention model description

meeting with a smoking cessation counsellor to discuss their individual requirements for smoking cessation and be offered their choice of pharmacological intervention. They will be provided with their choice of pharmacotherapy on site.They will then be invited to attend a group session, where they will have some brief lung function tests and check carbon monoxide levels. Participants will be offered refreshments and receive a bespoke group session to address various aspects of smoking cessation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or Female, aged 18 years or over * Willing and able to give informed consent for participation in the study. * Must work for PHT at QAH and be able to attend weekly meetings for the duration of the study period * Must be a current smoker

Exclusion criteria

-Unable to comprehend the study and provide informed consent e.g. insufficient command of English in the absence of someone to adequately interpret.

Design outcomes

Primary

MeasureTime frameDescription
Behavioural outcomes4 weeksNumber of smokers who achieve a successful quit

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026